Summit Global Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,772
| Closed | -$1.76M | – | 513 |
|
|
2025
Q1 | $1.76M | Sell |
2,772
-7,342
| -73% | -$4.66M | 0.13% | 97 |
|
|
2024
Q4 | $7.21M | Sell |
10,114
-1,754
| -15% | -$1.25M | 0.45% | 51 |
|
|
2024
Q3 | $12.5M | Buy |
11,868
+2,195
| +23% | +$2.31M | 0.8% | 27 |
|
|
2024
Q2 | $10.2M | Sell |
9,673
-2,651
| -22% | -$2.79M | 0.69% | 33 |
|
|
2024
Q1 | $11.9M | Sell |
12,324
-3,915
| -24% | -$3.77M | 0.88% | 29 |
|
|
2023
Q4 | $14.3M | Buy |
16,239
+15,931
| +5,172% | +$14M | 0.93% | 21 |
|
|
2023
Q3 | $254K | Buy |
308
+8
| +3% | +$6.6K | 0.02% | 453 |
|
|
2023
Q2 | $216K | Buy |
+300
| New | +$216K | 0.01% | 499 |
|
|
2021
Q4 | – | Sell |
-18,835
| Closed | -$11.4M | – | 594 |
|
|
2021
Q3 | $11.4M | Buy |
18,835
+2,535
| +16% | +$1.53M | 0.85% | 31 |
|
|
2021
Q2 | $9.09M | Buy |
16,300
+713
| +5% | +$398K | 0.54% | 36 |
|
|
2021
Q1 | $7.38M | Buy |
15,587
+14,779
| +1,829% | +$6.99M | 0.47% | 50 |
|
|
2020
Q4 | $390K | Buy |
808
+207
| +34% | +$99.9K | 0.04% | 216 |
|
|
2020
Q3 | $336K | Buy |
+601
| New | +$336K | 0.03% | 213 |
|